MARKET WIRE NEWS
Download Market Wire News App

Invivyd Inc. (NASDAQ : IVVD) Stock

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.


Description


Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19.


Quote


Last:$0.5402
Change Percent: -6.67%
Open:$0.5816
Close:$0.5402
High:$0.5981
Low:$0.5348
Volume:1,424,442
Last Trade Date Time:07/31/2026 02:34:59 pm

Stock Data


Market Cap:$379,990,219
Float:86,954,817
Insiders Ownership:0.02%
Institutions:28
Short Percent:N/A
Industry:Biotechnology & Life Sciences
Sector:Healthcare
Website:https://www.invivyd.com
Country:US
City:New Haven

Recent News Releases


Subscribe to Our Newsletter


Message Board Posts


investorshub : Lugnut
investorshub : glenn1919

**MWN-AI FAQ is based on asking OpenAI questions about Invivyd Inc. (NASDAQ: IVVD).

Link Market Wire News to Your X Account

Download The Market Wire News App